<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01372631</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00028284</org_study_id>
    <secondary_id>5R01EB011574</secondary_id>
    <nct_id>NCT01372631</nct_id>
  </id_info>
  <brief_title>A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins</brief_title>
  <official_title>A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute for Biomedical Imaging and Bioengineering (NIBIB)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <brief_summary>
    <textblock>
      The goal of this research is to further develop novel optical assay systems for intra
      operative assessment of tumor margins in partial mastectomy or mastectomy specimens.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this research is to further develop novel optical assay systems for intra
      operative assessment of tumor margins in partial mastectomy or mastectomy specimens. We are
      seeking to establish the accuracy of first and second-generation prototypes of technologies
      utilizing optical spectroscopy for intra operative margin assessment in partial mastectomy or
      mastectomy specimens. The aims associated with this research are as follows, (1) to evaluate
      the device-tissue interface on reduction mammoplasty specimens from a total of 20 patients,
      (2) to assess random and systematic errors of the new miniature system on mastectomy
      specimens from a total of 40 patients (3) to test the sensitivity, and specificity of the
      miniature spectral imaging system for margin assessment on excised partial mastectomy or
      mastectomy specimens from a total of 150 patients undergoing breast conserving surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of the optical signatures in breast tissue</measure>
    <time_frame>Day of procedure (less than 10 minutes)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and Specificity of the device</measure>
    <time_frame>Day of procedure (less than 10 minutes)</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Pressure assessment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 patients undergoing lumpectomy, mastectomy or reduction mammoplasty will be enrolled to assess the ideal pressure that should be applied when taking optical measurements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Random and Systematic Errors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>40 patients undergoing lumpectomy or mastectomy will be enrolled to assess the random and systematic errors of the miniature spectral imaging system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sensitivity and Specificity Assessment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>150 patient undergoing lumpectomy, mastectomy or reduction mammoplasty will be enrolled in order to determine the sensitivity and specificity of the miniature spectral imaging system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>miniature spectral imaging system</intervention_name>
    <description>Use of miniature spectral imaging system</description>
    <arm_group_label>Pressure assessment</arm_group_label>
    <arm_group_label>Random and Systematic Errors</arm_group_label>
    <arm_group_label>Sensitivity and Specificity Assessment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bench-top optical spectrometer</intervention_name>
    <description>Use of bench-top optical spectrometer</description>
    <arm_group_label>Pressure assessment</arm_group_label>
    <arm_group_label>Random and Systematic Errors</arm_group_label>
    <arm_group_label>Sensitivity and Specificity Assessment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High resolution microendoscope</intervention_name>
    <description>Use of high resolution microendoscope</description>
    <arm_group_label>Sensitivity and Specificity Assessment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing a reduction mammoplasty OR

          -  Patients undergoing a lumpectomy mastectomy for the treatment of an invasive or
             non-invasive breast malignancy

          -  Age &gt; 18

          -  Clinically detectable disease either by physical examination or radiographic studies

          -  Patients of all ethnic and gender groups will be included. Protocol accrual will be
             reviewed annually to include a determination of minority and gender representation. If
             accrual demonstrates under-representation of any group with comparison to disease
             incidence in that group, appropriate measures will be undertaken to increase
             participation of patients of that minority or gender group

          -  Ability to understand and the willingness to sign a written informed consent document.

        Exclusion Criteria:

          -  Patients considered in &quot;vulnerable&quot; populations.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nimmi Ramanujam, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nimmi Ramanujam, Ph.D.</last_name>
    <phone>919-660-5703</phone>
    <email>nimmi@duke.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marlee Krieger, M.S.</last_name>
    <phone>919-660-8446</phone>
    <email>marlee.krieger@duke.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nimmi Ramanujam, Ph.D.</last_name>
      <phone>919-660-5307</phone>
      <email>nimmi@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Nimmi Ramanujam, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin - Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>54706</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2011</study_first_submitted>
  <study_first_submitted_qc>June 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2011</study_first_posted>
  <last_update_submitted>April 9, 2018</last_update_submitted>
  <last_update_submitted_qc>April 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reduction mammoplasty</keyword>
  <keyword>mastectomy</keyword>
  <keyword>partial mastectomy</keyword>
  <keyword>lumpectomy</keyword>
  <keyword>breast conserving surgery</keyword>
  <keyword>breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

